A pilot phase II trial of celecoxib in patients with grade 2 or 3 endometrioid-type, clear cell, and papillary serous uterine cancers.

Trial Profile

A pilot phase II trial of celecoxib in patients with grade 2 or 3 endometrioid-type, clear cell, and papillary serous uterine cancers.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 23 Apr 2012

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Uterine cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Apr 2012 Actual end date (1 Mar 2004) added as reported by ClinicalTrials.gov.
    • 23 Apr 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top